financetom
Business
financetom
/
Business
/
US FDA approves Vanda's drug for bipolar disorder
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Vanda's drug for bipolar disorder
Apr 2, 2024 3:22 PM

April 2 (Reuters) - The U.S. FDA approved Vanda

Pharmaceuticals' ( VNDA ) drug to treat manic and mixed episodes

associated with a type of bipolar disorder, the company said on

Tuesday, marking the second approval for the treatment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved